iTind Device Receives FDA de Novo Classification Order for Benign Prostatic Hyperplasia: A Non-Surgical Treatment Device
The iTind device was developed by the Israeli-based medical device manufacturer Medi-Tate.
US based NEXVOO Announces the Availability of Additional FDA and CE PPE
NEXVOO announced that it is assisting with the US and global pandemic by expanding its resources to offer additional PPE products into the US.
Trial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein
Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.
FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19
The U.S. Food and Drug Administration continues to play a critical role in accelerating medical countermeasures to treat and prevent COVID-19. As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood.
3M Issues Statement in Response to the Announcements Issued by the White House Last Evening
Over the last several weeks and months, 3M and its employees have gone above and beyond to manufacture as many N95 respirators as possible for the U.S. market. Yesterday, the Administration formally invoked the Defense Production Act (DPA) to require 3M to prioritize orders from the Federal Emergency Management Agency (FEMA) for our N95 respirators.